Differences in pharmacokinetics may account for the trend toward lower HIV infection rates with FTC/TAF vs FTC/TDF as PrEP in MSM and transgender women enrolled on the phase III DISCOVER trial.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address Clinical Care Options, LLC 12001 Sunrise Valley Drive Suite 300 Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
Continue